ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Achieve Life Sciences Announces Positive Results for Simplified Cytisinicline Dosing Schedule
June 13, 2019Achieve Life Sciences has announced positive results from the ORCA-1 dose-selection trial of cytisinicline for smoking cessation. The outcome of the 254-subject, ORCA-1 trial is the selection of 3.0 mg, three times daily (TID) for Phase 3 development. -
World's First Digital nicotine-dependent Treatment App from CureApp for higher sustained smoking cessation (CAR) rate
June 03, 2019CureApp Smoking Cessation helps to quit smoking through smartphone Apps and portable CO inspectors by providing daily support to patients
Pharma Sources Insight January 2025
